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Abstract
Background: Corn silk contains proteins, vitamins, carbohydrates, Ca, K, Mg and Na salts, fixed
and volatile oils, steroids such as sitosterol and stigmasterol, alkaloids, saponins, tannins, and
flavonoids. Base on folk remedies, corn silk has been used as an oral antidiabetic agent in China for
decades. However, the hypoglycemic activity of it has not yet been understood in terms of modern
pharmacological concepts. The purpose of this study is to investigate the effects of corn silk on
glycaemic metabolism.
Methods: Alloxan and adrenalin induced hyperglycemic mice were used in the study. The effects
of corn silk on blood glucose, glycohemoglobin (HbA1c), insulin secretion, damaged pancreatic β-
cells, hepatic glycogen and gluconeogenesis in hyperglycemic mice were studied respectively.
Results: After the mice were orally administered with corn silk extract, the blood glucose and the
HbA1c were significantly decreased in alloxan-induced hyperglycemic mice (p < 0.05, p < 0.01,
respectively), while the level of insulin secretionn was markedly elevated in alloxa-induced
hyperglycemic mice (p < 0.05). The alloxan-damaged pancreatic β-cells of the mice were partly
recovered gradually after the mice were administered with corn silk extract 15 days later. Also, the
body weight of the alloxan-induced hyperglycemic mice was increased gradually. However,
ascension of blood glucose induced by adrenalin and gluconeogenesis induced by L-alanine were
not inhibited by corn silk extract treatment (p > 0.05). Although corn silk extract increased the
level of hepatic glycogen in the alloxan-induced hyperglycemic mice, there was no significant
difference between them and that of the control group(p > 0.05).
Conclusion: Corn silk extract markedly reduced hyperglycemia in alloxan-induced diabetic mice.
The action of corn silk extract on glycaemic metabolism is not via increasing glycogen and inhibiting
gluconeogenesis but through increasing insulin level as well as recovering the injured β-cells. The
results suggest that corn silk extract may be used as a hypoglycemic food or medicine for
hyperglycemic people in terms of this modern pharmacological study.
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Background
Corn silk (ZeamaysL.) refers to the stigmas from the
female flowers of maize. Fresh corn silk resembles soft silk
threads 10-20 cm long that are either light green or yel-
low-brown in color. Corn silk contains proteins, vitamins,
carbohydrates, Ca, K, Mg and Na salts, fixed and volatile
oils, steroids such as sitosterol and stigmasterol, alkaloids,
saponins, tannins, and flavonoids [1-14]. There have been
many reports on the biological activities of corn silk con-
stituents. Methanol extracts of corn silk showed an antiox-
idative activity on the level of lipid peroxidation [15].
Volatiles from corn silk inhibited the growth of Aspergil-
lus flavus, indicating that it has an antifungal activity [16].
In addition, extract of corn silk inhibited TNF and LPS-
induced cell adhesion, but not cytotoxic activity or TNF
production [17].
Corn silk has been used in many parts of the world for the
treatment of edema as well as for cystitis, gout, kidney
stones nephritis and prostatitis [13,18]. Base on folk rem-
edies, corn silk has been used as an oral antidiabetic agent
in China for decades. However, in spite of its widespread
use, the mechanisms underlying hypoglycemic activity of
corn silk was not yet understood. Therefore, the purpose
of this study was to investigate the effects of corn silk on
glycaemic metabolism. The effects of corn silk on blood
glucose, HbA1c, insulin secretion, damaged pancreatic β-
cells, hepatic glycogen and gluconeogenesis in hyperglyc-
emic mice were studied respectively.
Materials and methods
Animals
Kunming strain mice weighing 20-22 g, Grade II, Certifi-
cate SCXK (Lu) 20080006, were purchased from the
Experimental Animal Center, Shandong University,
China. The mice were maintained at room temperature
under alternating natural light/dark photoperiod, and
had access to standard laboratory food and fresh water ad
libitum. This study was performed in accordance with the
Guide for the Care and Use of Laboratory Animals. Care
was taken to minimize discomfort, distress, and pain to
the animals.
Chemicals
Alloxan and adrenaline were analytical grade. Alloxan was
purchased from Sigma Co., Ltd and adrenaline was pur-
chased from Tianjin Amino acid Co., Ltd. China. Xiaoke
pills were purchased from Jilin Liuhe Pharmaceutic Fac-
tory, China. Xiaoke pill is a kind of Chinese medicine
used in the treatment of diabetes. It is composed of glib-
enclamide and several traditional Chinese herbs, includ-
ing Radix Puerariae, Radix Rehmannia, Radix Astragali,
Radix Trichosanthis, Corn Stigma, Fructus Schisandrae
and Rhizoma Dioscoreae.
Corn silk extract (CSE) preparation
Corn silk was obtained from local market. Sample was
produced by the way introduced by Velazquez [1]. Briefly,
corn silk was dried at room temperature (24.2 ± 1.0°C)
and an aqueous extraction was performed by adding 100
ml boiling water to 10 g corn silk, filtering after 20 min
and then lyophilizing.
Experimental design
Blood samples from alloxan-induced hyperglycemic mice
One hundred mice were fasted for 12 h and then injected
(iv) with alloxan (75 mg/kg) dissolved in sterile saline
[19]. Forty-eight hours later, blood samples were collected
from the tail veins of the mice. The blood glucose was ana-
lyzed with a Glucometer-4 (Bayer). Sixty hyperglycemic
mice (the blood glucose level greater than 11.1 mmol/L)
were selected and randomly divided into 6 groups. From
then on, the 6 groups of mice were administered orally
saline (control), Xiaoke Pill and 0.5, 1.0, 2.0 or 4.0 g/kg
body wt. of corn silk extract (CSE) dissolved in the same
amount of saline (experimental). The body weights of the
mice were measured on the 0th day, 5th day, 10th day, 15th
day and the 20th day. At the same time, after fasting the
mice for 12 h on the 20th  day, blood samples were
obtained from the tail veins to determine the blood glu-
cose levels. On the 45th day, blood samples were collected
from the orbital veins to measure the HbA1c with the
HbA1c Apparatus (Variantα, Bio-Rad Laboratories) and
insulin with an enzyme-linked immunosorbant assay
(ELISA) kit (Biosource, Europe) respectively [20]. Then,
the mice were sacrificed. The pancreas was dissected out
and placed in 10% buffered formalin and the liver was
dissected out for the measurement of hepatic glycogen.
Estimation of the damaged pancreatic β-cells
The pancreatic tissues were embedded in paraffin blocks after 
formalin fixation
Paraffin sections were cut at 4- μm thickness and were
deparaffinized in xylene twice for 5 min and then were
rehydrated with the graded ethanol. The sections were
examined after hematoxylin and eosin (H&E) staining
[21].
Estimation of hepatic glycogen
The liver was homogenized in ice-cold 0.6 M HClO4. The
mixture was immediately centrifuged at 3000 g for 10 min
at 4°C to obtain the supernatant. Free glucose in the tissue
was measured with the glucose oxidase method. Amy-
loglucosidase solution (10 U/ml) in 0.2 M sodium acetate
buffer (pH 4.8) was then mixed and incubated in the mix-
ture at 40°C for 2 h. After incubation, pH of the mixture
was adjusted to 7 and subjected to determination of total
glucose. Free glucose was subtracted from total glucose to
obtain glycogen content. The glycogen was expressed as
mg/g wet tissue [22].Nutrition & Metabolism 2009, 6:47 http://www.nutritionandmetabolism.com/content/6/1/47
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Estimation of gluconeogenesis
Thirty normal mice were selected and allocated equally
into 3 groups: Xiaoke Pill-treated group, CSE-treated
group and saline group used as the control group. From
then on, these 3 groups of mice were administered orally
with Xiaoke Pill, CSE (4.0 g/kg) and saline respectively. At
the end of the experimental period (15 days later), ani-
mals were fasted 12 h. After administration 1 h later, the
mice were injected (s.c.) with L-alanine. The blood sam-
ples from the tail vein of the mice were collected at the 0th
min and 60th min to determine blood glucose level.
Blood samples from adrenaline -induced hyperglycemic mice
Sixty healthy mice were allocated equally into 6 groups.
Then these 6 groups of mice were also orally administered
with saline, Xiaoke Pill and CSE (0.5, 1.0, 20. and 4.0 g/
kg), respectively. On the 14th day, they were fasted over
night. After administration 1 h later, animals were
injected (sc) with adrenaline. Blood samples from the tail
vein of the mice were collected at the 0th min and 60th min
to determine blood glucose level just as above.
Statistical analysis
All data were analyzed by a one-way analysis of variance,
and the differences between means were established by
Duncan's multiple-range test [23]. The data represents
means and standard deviations. The significant level of
5% (p <0.05) was used as the minimum acceptable prob-
ability for the difference between the means.
Results and Discussion
Alloxan and streptozotocin are the most prominent diabe-
togenic chemicals in diabetes research. Both are toxic glu-
cose analogues that preferentially accumulate in
pancreatic beta cells via the GLUT2 glucose transporter
[24-28]. Streptozotocin is split into its glucose and meth-
ylnitro-sourea moiety. Owing to its alkylating properties,
the latter modifies biological macromolecules, fragments
DNA and destroys the beta cells, causing a state of insulin-
dependent diabetes (type 1 diabetes mellitus) [27,28]. On
the other hand, alloxan has two distinct pathological
effects: it selectively inhibits glucose-induced insulin
secretion through specific inhibition of glucokinase, the
glucose sensor of the beta cell, and it causes a state of insu-
lin-dependent diabetes by selective necrosis of beta cells
in type 1 and type 2 diabetes mellitus [24-26]. So alloxan
is the agent of choice for induction of diabetic experimen-
tal animals in this study.
The body weights of the hyperglycemic mice induced by
alloxan are presented in Fig. 1. Contrasted with the con-
trol group, the body weights of mice in CSE-treated group
were increased gradually 20 days later (p < 0.05, p < 0.01).
The body weights of mice in Xiaoke Pill-treated group
were also increased. The body weights of hyperglycemic
mice induced by alloxan were increased when they were
administrated with CSE. It indicates that corn silk could
act as supplement nutrients to mice.
The results of blood glucose from hyperglycemic mice
induced by alloxan are presented in Table 1. The levels of
blood glucose were decreased after administration of
CSE(2.0 and 4.0) and the Xiaoke Pill (p < 0.05). However,
low doses CSE-treated groups (0.5 and 1.0 g/kg) did not
reach the same result. The mechanisms of the hypoglycae-
mic effects of CSE have been also studied in this paper. As
shown in Table 2, the levels of serum insulin were ele-
vated after administration of 4.0 g/kg body wt CSE (9.8 ±
0.5 μU/mL p < 0.05) and the Xiaoke Pill (8.6 ± 0.7 μU/
mL). However, the same results did not occur in the saline
treated group(3.8 ± 0.4 μU/mL) throughout the total
duration of the study. It is possible that CSE could aid in
releasing of insulin from the surviving β-cells, as well from
the recovered β-cells by CSE. The β-cells of the mice fed
with CSE (4.0 g/kg) were partially recovered (Fig. 2). β-
Cells death and alteration of islet cell population were
prominent in the diabetic mice (Fig. 2A). In contrast, the
cell damage was not observed in the islet cells of the CSE-
fed mice in spite of the alloxan treatment (Fig. 2B).
Effects of CSE on body weights of hyperglycemic mice Figure 1
Effects of CSE on body weights of hyperglycemic 
mice. Values are means ± SEM, n = 10. *Different from con-
trol group P < 0.05; **different from control group, P < 0.01.
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Table 1: Effect of CSE on blood glucose levels in alloxan-
hyperglycemic mice
Different groups Blood glucose (mmol/L)
Control group 21.2 ± 2.1b
Xiaoke Pill-treated 13.4 ± 3.0a
CSE(4.0)-treated 11.5 ± 2.1a
CSE(2.0)-treated 15.6 ± 3.0A
CSE(1.0)-treated 18.9 ± 2.8b
CSE(0.5)-treated 19.9 ± 2.7b
Values are shown as means ± SEM, n = 10. The different letters in the 
same column indicate a statistical difference (p < 0.05)Nutrition & Metabolism 2009, 6:47 http://www.nutritionandmetabolism.com/content/6/1/47
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HbA1c is a more useful parameter in diabetes. CSE(4.0 g/
kg) could decrease the concentration of HbA1c in plasma
of alloxan- induced hyperglycemic group 45 days later (p
< 0.01), as shown in Table 3. However the same result did
not occur in other groups.
Adrenaline activates glycogenolysis and glyconeogenesis
to elevate serum glucose level [29] and its effect is rela-
tively rapid [30]. The results of blood glucose from hyper-
glycemic mice induced by adrenaline are presented in
Table 4. It showed that ascension of blood glucose
induced by adrenaline was not inhibited (p > 0.05) after
mice were administered orally with CSE for 15 days. It
indicates that the mechanisms of the hypoglycaemic
effects of CSE might via increasing insulin level as well as
recovering the injured β-cells but not through inhibiting
gluconeogenesis and glycogenolysis. It is consistent with
the results presented in Table 1, 3, 5 and 6.
Glycogen storage in the liver is another way to maintain
blood glucose concentration in mammals. Decreased
hepatic glucose production is induced by glycogen synthe-
sis and the treatment effects of CSE were further con-
firmed by the assay of evaluating glycogen storage in the
liver. CSE treatment increased the level of hepatic glyco-
gen. The glycogen levels were 17.0 ± 4.2 mg/g tissue in
CSE treated mice. Concentrations of hepatic glycogen
were lower in saline-treated mice (14.2 ± 3.4 mg/g) than
those in CSE treated mice(Table 5). However, there was
no significant difference between them (p > 0.05).
As shown in Table 6, At the 60th min, the level of blood
glucose of the mice in the CSE group was increased from
Table 2: Effect of CSE on serum insulin level in alloxan-induced 
diabetic mice
Different groups Serum insulin (μU/mL)
Saline-treated 3.8 ± 1.4a
Xiaoke Pill-treated 8.6 ± 0.7b
CSE (4.0)-treated 9.8 ± 0.5b
Values are shown as means ± SEM, n = 10. The different letters in the 
same column indicate a statistical difference. CSE-treated groups 
were compared with diabetic group, p < 0.05.
Islet cell death and replication represented by hematoxylin--eosin Figure 2
Islet cell death and replication represented by hematoxylin--eosin. The islet cells of diabetic mice of alloxan-treat-
ment (A) showed extensive cell lysis, representing loss of plasma membrane with condensed nuclei and dissolved cytoplasm in 
wide intercellular spaces. In contrast, the islet cells of CSE(4.0)-fed mice (B) and Xiaoke Pill-treated (D) mice were partly 
recovered. The islet cells of CSE(2.0)-fed mice was C.
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92.1 ± 17.9 mg/mL to 102.6 ± 9.0 mg/mL at the 60th min,
after the mice were injected (s.c.) with L-alanine. At the
same time, the level of blood glucose of the mice in the
control group was increased after the mice were injected
(s.c.) with L-alanine (from 91.6 ± 14.7 mg/mL to 100.0 ±
12.2 mg/mL). The result was shown in Table. 6 (p > 0.05).
Gluconeogenesis is one of the key metabolic pathways in
the liver. It is an important mechanism for maintaining
blood glucose within a normal range. The result shown in
Table. 6 indicates that the mechanisms of the hypoglycae-
mic effects of CSE were not by inhibiting gluconeogenesis.
Conclusion
Our results showed that CSE treatment markedly reduced
hyperglycemia in alloxan -induced diabetic mices. The
action of CSE on glycaemic metabolism is not via increas-
ing glycogen and inhibiting gluconeogenesis but through
increasing insulin level as well as recovering the injured β-
cells.
Table 3: Effect of CSE on HbA1c from hyperglycemic mice induced by alloxan (%)
Different groups Results of HbA1c
Control group 11.8 ± 0.23b
Xiaoke Pill-treated 9.9 ± 0.30b
CSE(4.0)-treated 6.9 ± 0.28a
CSE(2.0)-treated 9.0 ± 0.26b
CSE(1.0)-treated 10.8 ± 0.33b
CSE(0.5)-treated 11.0 ± 0.22b
Values are shown as means ± SEM, n = 10. The different letters in the same column indicate a statistical difference (p < 0.01)
Table 4: Effect of CSE on blood glucose levels in adrenaline -hyperglycemic mice
Different groups Blood glucose (mmol/L)
at 0th min
Blood glucose (mmol/L)
at 60th min
Control group 5.7 ± 2.6 15.1 ± 1.0
Xiaoke Pill-treated 5.6 ± 2.2 12.3 ± 0.6*
CSE(4.0)-treated 5.8 ± 3.1 12.6 ± 1.5*
CSE(2.0)-treated 5.6 ± 2.6 14.0 ± 1.2*
CSE(1.0)-treated 5.7 ± 2.3 13.9 ± 1.6*
CSE(0.5) -treated 5.7 ± 3.3 15.0 ± 3.2*
Values are shown as means ± SEM, n = 10. * p > 0.05 vs. Control group
Table 5: Effect of CSE on hepatic glycogen
Different groups Hepatic glycogen (mg/g tissue)
Saline-treated 14.2 ± 3.4
Xiaoke Pill-treated 16.8 ± 0.5*
CSE (4.0)-treated 17.0 ± 4.2*
Values are shown as means ± SEM, n = 10. * p > 0.05 vs. Saline - treated group.
Table 6: Effect of CSE on Gluconeogenesis
Different groups Blood glucose (mg/mL)
at 0th min
Blood glucose (m/mL)
at 60th min
Xiaoke Pill-treated 92.5 ± 15.5 99.8 ± 11.9*
CSE (4.0)-treated 92.1 ± 17.9 102.6 ± 9.0*
Saline-treated 91.6 ± 14.7 100.0 ± 12.2
Values are shown as means ± SEM, n = 10. * p > 0.05 vs. Saline - treated group.Publish with BioMed Central    and   every 
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